Neuland Laboratories Limited (NEULANDLAB.NS)
INR 14614.8
(-1.24%)
INR 14614.8
(-1.24%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 2.55 Billion | 2.38 Billion | 585.8 Million | 1.89 Billion | 573.41 Million | 699.07 Million |
| Net Income | 3 Billion | 2.15 Billion | 821.62 Million | 1.05 Billion | 529.22 Million | 203.37 Million |
| Depreciation & Amortization | 596.99 Million | 527.76 Million | 490.4 Million | 396.82 Million | 312.8 Million | 258.62 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -907.31 Million | -91.72 Million | -675.84 Million | 492.16 Million | -491.72 Million | 154.7 Million |
| Other non-cash items | 1.65 Billion | -202.84 Million | -50.37 Million | -48.7 Million | 223.11 Million | 82.37 Million |
| Investing Cash Flow | -1.57 Billion | -614.97 Million | -937.08 Million | -844.23 Million | -486.79 Million | -772.29 Million |
| Investments in PPE | -1.43 Billion | -661.27 Million | -958.77 Million | -1.05 Billion | -487.96 Million | -631.11 Million |
| Acquisitions | 12.63 Million | 14.91 Million | 4.36 Million | 85 Thousand | 7.8 Million | 3.79 Million |
| Investment purchases | -155.1 Million | -14.91 Million | -10.14 Million | -188.21 Million | -58.7 Million | -159.38 Million |
| Sales/Maturities of investments | 3.36 Million | 15.99 Million | 16.6 Million | 188.13 Million | 50.9 Million | 155.59 Million |
| Other Investing Activities | -60.17 Million | 30.3 Million | 10.87 Million | 209.73 Million | 1.17 Million | -141.17 Million |
| Financing Cash Flow | -558.99 Million | -1.35 Billion | 377.21 Million | -1.13 Billion | -54.8 Million | 119.77 Million |
| Debt repayment | -394.4 Million | -356.23 Million | -222.6 Million | -1.26 Billion | -223.52 Million | -1 Billion |
| Dividends payments | -128.29 Million | -64.14 Million | -38.49 Million | -25.66 Million | -49.49 Million | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | 1.24 Billion |
| Other Financing Activities | -252.12 Million | -937.57 Million | 638.31 Million | 149.33 Million | 218.21 Million | -119.17 Million |
| Accounts receivables | -86.62 Million | -1.34 Billion | -171 Million | -300.75 Million | -294.99 Million | 315.36 Million |
| Accounts payables | 203.28 Million | 543.59 Million | -397.17 Million | 366.45 Million | -47.28 Million | -21.83 Million |
| Inventory | -711.88 Million | -140.23 Million | -176.02 Million | -280.6 Million | -268.93 Million | -175.66 Million |
| Other working capital | -312.08 Million | 848.19 Million | 68.34 Million | 707.06 Million | 119.48 Million | 36.83 Million |
| Cash at beginning of period | 455.32 Million | 37.18 Million | 24.35 Million | 112.03 Million | 79.37 Million | 32.87 Million |
| Cash at end of period | 1.16 Billion | 449.57 Million | 50.91 Million | 24.35 Million | 112.03 Million | 79.37 Million |
| Capital Expenditure | -1.43 Billion | -661.27 Million | -958.77 Million | -1.05 Billion | -487.96 Million | -631.11 Million |
| Effect of forex changes on cash | -486 Thousand | 4.06 Million | 618 Thousand | -455 Thousand | 846 Thousand | -52 Thousand |
| Net cash flow / Change in cash | 712.63 Million | 412.39 Million | 26.55 Million | -87.67 Million | 32.65 Million | 46.49 Million |
| Free Cash Flow | 1.12 Billion | 1.72 Billion | -372.97 Million | 839.64 Million | 85.44 Million | 67.95 Million |
| Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 978.72 Million | 675.61 Million | 3 Billion | 813.9 Million | 892.47 Million | 618.79 Million |
| Depreciation & Amortization | - | - | 596.99 Million | 151.43 Million | 145.07 Million | 135.85 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | -907.31 Million | - | - | - |
| Other non-cash items | -978.72 Million | -675.61 Million | 1.65 Billion | -813.9 Million | -892.47 Million | -618.79 Million |
| Investing Cash Flow | - | - | -1.57 Billion | - | - | - |
| Investments in PPE | - | - | -1.43 Billion | - | - | - |
| Acquisitions | - | - | 12.63 Million | - | - | - |
| Investment purchases | - | - | -155.1 Million | - | - | - |
| Sales/Maturities of investments | - | - | 3.36 Million | - | - | - |
| Other Investing Activities | - | - | -60.17 Million | - | - | - |
| Financing Cash Flow | - | - | -558.99 Million | - | - | - |
| Debt repayment | - | - | -394.4 Million | - | - | - |
| Dividends payments | - | - | -128.29 Million | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | -252.12 Million | - | - | - |
| Accounts receivables | - | - | -86.62 Million | - | - | - |
| Accounts payables | - | - | 203.28 Million | - | - | - |
| Inventory | - | - | -711.88 Million | - | - | - |
| Other working capital | - | - | -312.08 Million | - | - | - |
| Cash at beginning of period | - | - | 455.32 Million | 1.36 Billion | 1.07 Billion | 455.32 Million |
| Cash at end of period | - | - | 1.16 Billion | 1.66 Billion | 1.36 Billion | 727.03 Million |
| Capital Expenditure | - | - | -1.43 Billion | - | - | - |
| Effect of forex changes on cash | - | - | -486 Thousand | - | - | - |
| Net cash flow / Change in cash | - | - | 712.63 Million | 302.87 Million | 290.15 Million | 271.71 Million |
| Free Cash Flow | - | - | 1.12 Billion | 302.87 Million | 290.15 Million | 271.71 Million |
AZZTF
3174
9602
NIVAKA
GEX
FVJ